These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10668419)

  • 1. Neuroprotective and cognitive enhancing effects of novel small peptides.
    Faden AI; Fox G; Fan L; Knoblach S; Araldi GL; Kozikowski AP
    Ann N Y Acad Sci; 1999; 890():120. PubMed ID: 10668419
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroendocrine effects of thyroliberin and its analogs.
    Babichev VN; Samsonova VM; Airapetyants MG; Kolomeitseva IA; Shvachkin YuP ; Smirnova AP
    Neurosci Behav Physiol; 1982; 12(5):394-7. PubMed ID: 6820125
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroprotective effects of novel small peptides in vitro and after brain injury.
    Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
    Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticipated and unexpected physiological effects of oligopeptides (glyprolines, ACTH (4-10) analogs, taftsin, and thyroliberin)].
    Ashmarin IP
    Ross Fiziol Zh Im I M Sechenova; 2001 Nov; 87(11):1471-6. PubMed ID: 11816278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents.
    Faden AI; Fox GB; Fan L; Araldi GL; Qiao L; Wang S; Kozikowski AP
    Am J Physiol; 1999 Oct; 277(4):R1196-204. PubMed ID: 10516262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel neuroprotective tripeptides and dipeptides.
    Faden AI; Knoblach SM; Movsesyan VA; Lea PM; Cernak I
    Ann N Y Acad Sci; 2005 Aug; 1053():472-81. PubMed ID: 16179555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions between TRH and 5-hydroxytryptamine (5-HT) and proctolin in rat brain and spinal cord.
    Marsden CA; Bennett GW; Fone KC; Johnson JV
    Ann N Y Acad Sci; 1989; 553():121-34. PubMed ID: 2566294
    [No Abstract]   [Full Text] [Related]  

  • 8. [TRH analogs at Gedeon Richter Ltd.: highlights of experimental and clinical efficacy of posatirelin].
    Sarkadi A; Kárpáti E
    Acta Pharm Hung; 2002; 72(1):62-8. PubMed ID: 12426788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH
    Rajput SK; Sharma AK; Meena CL; Pant AB; Jain R; Sharma SS
    Biomed Pharmacother; 2016 Dec; 84():1256-1265. PubMed ID: 27810782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
    Yamamoto M; Ozawa Y; Takeuchi H
    Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional drug treatment in neurotrauma.
    Stoica B; Byrnes K; Faden AI
    Neurotherapeutics; 2009 Jan; 6(1):14-27. PubMed ID: 19110196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo.
    Faden AI; Knoblach SM; Cernak I; Fan L; Vink R; Araldi GL; Fricke ST; Roth BL; Kozikowski AP
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):342-54. PubMed ID: 12621309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophin infusion improves cognitive deficits and decreases cholinergic neuronal cell loss after experimental brain injury.
    Sinson G; Voddi M; Flamm ES; McIntosh TK
    Clin Neurosurg; 1996; 43():219-27. PubMed ID: 9247806
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
    MacGregor JS; Resnick LM; Laragh JH
    Biochem Biophys Res Commun; 1982 Nov; 109(2):556-61. PubMed ID: 6295402
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure activity relationship studies with hypothalamic peptide hormones. II. Effects of thyrotropin releasing hormone analogs on morphine-induced responses in mice.
    Bhargava HN; Matwyshyn GA; Currie BL; Goebel RJ
    Life Sci; 1982 Mar; 30(9):711-8. PubMed ID: 6803094
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
    Weinstock M; Kirschbaum-Slager N; Lazarovici P; Bejar C; Youdim MB; Shoham S
    Ann N Y Acad Sci; 2001 Jun; 939():148-61. PubMed ID: 11462767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
    Dixon DM; Fone KC; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro.
    Stelmashook EV; Genrikhs EE; Novikova SV; Barskov IV; Gudasheva TA; Seredenin SB; Khaspekov LG; Isaev NK
    Int J Neurosci; 2015 May; 125(5):375-9. PubMed ID: 24950445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
    Shimizu M; Yamamoto M; Kobayashi M
    Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.